GlassScriptPhysician profile
Aaron Lee Egbert
NPI 1265453831
$2,394.17
in general payments reported to CMS, 2019-2025
18 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $426 · 2024: $1,614 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,296 · Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,296.11 |
| Food and Beverage | $962.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,472.65 | 2024 | |
| Medtronic, INC. | $184.95 | 2023-2025 | Corevalve Evolut R, Avalus, Endo Gia Ultra |
| Abbott Laboratories | $182.66 | 2023-2024 | 2nd Gen Centrimag Primary Console, Gallant, Jot Dx |
| Edwards Lifesciences Corporation | $98.93 | 2023-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Bayer Healthcare Pharmaceuticals INC. | $77.32 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $53.02 | 2022 | |
| Pfizer INC. | $49.09 | 2022-2025 | |
| Abiomed | $38.68 | 2023 | Impella |
| Lemaitre Vascular, INC. | $37.08 | 2023 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Prism Medical | $36.32 | 2024 | |
| Acist Medical Systems, INC. | $28.45 | 2023 | |
| Atricure, INC. | $25.66 | 2024 | |
| Boston Scientific Corporation | $23.37 | 2024 | Angiojet Ultra 5000a |
| Amgen INC. | $21.69 | 2024 | Repatha |
| Organogenesis INC. | $19.96 | 2023 | Puraply |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.81 | 2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Egbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.